2.Advances of spatial omics in the individualized diagnosis and treatment of head and neck cancer.
Chenyang XU ; Yin WANG ; Dongmin WEI ; Wenming LI ; Ye QIAN ; Xinliang PAN ; Dapeng LEI
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(9):729-739
Spatialomics is another research hotspot of biotechnology after single-cell sequencing technology, which can make up for the defect that single-cell sequencing technology can not obtain cell spatial distribution information. Spatialomics mainly studies the relative position of cells in tissue samples to reveal the effect of cell spatial distribution on diseases. In recent years, spatialomics has made new progress in the pathogenesis, target exploration, drug development and many other aspects of head and neck tumors. This paper summarizes the latest progress of spatialomics in the diagnosis and treatment of head and neck cancer.
Humans
;
Head and Neck Neoplasms/therapy*
4.Diagnosis and treatment of unusually located paragangliomas in head and neck: a report of 2 cases.
Feng XU ; Jing-qi TIAN ; Ying-chun XU ; Li-wei MENG ; Ai-jing SUN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(6):519-520
Head and Neck Neoplasms
;
diagnosis
;
therapy
;
Humans
;
Neck
;
Paraganglioma
;
diagnosis
;
therapy
6.Oral Care Management of Head and Neck Cancer Patients at Hospital Universiti Sains Malaysia: A 7-Year Retrospective Study
Huikai Chew ; Kasmawati Mokhtar ; Yew Hin Beh ; Wan Mohd Nazri Wan Zainon ; Azirrawani Ariffin
Archives of Orofacial Sciences 2022;17(1):47-59
ABSTRACT
Head and neck cancer patients require oral assessment and management prior, during and after cancer
treatment to minimise oral complications. Hence, this study aimed to evaluate sociodemographic data,
oral health management, oral complications derived from cancer treatment, time frame in completing
dental treatment and association between oral management and complications. Purposive record
sampling of head and neck cancer patients who completed radiotherapy and/or chemotherapy at
Hospital Universiti Sains Malaysia (HUSM) from 2011 to 2017 were reviewed. A checklist was used
to record the data and analysed using descriptive statistics and Pearson Chi-square test. A number
of 194 patient records were reviewed with majority were Malays (88.1%), males (61.3%) with the
mean age of 57.18 years old. Only 21% of the patients had oral assessment prior to cancer treatment.
About 84% of the referred patients were dentally fit within 1 month. Mucositis and fungal infections
were the most prevalent complications. The relationship between oral assessment prior to cancer
treatment and oral complications was not significant (p = 0.134). Despite the insignificant association
due to several limitations, oral assessment and management prior, during and after cancer therapy
are recognised as crucial for improving quality of life. A standard institutional operating procedure is
recommended to improve patient care.
Head and Neck Neoplasms--therapy
;
Dental Care
7.EAP combination chemotherapy in patients with advanced head and neck cancer.
Ill Kuk YOON ; Jun Yung KIL ; Eul Gun CHUN ; Jong Wan KIM ; Samyong KIM ; Jang Yuorl YOO
Journal of the Korean Cancer Association 1991;23(2):380-386
No abstract available.
Drug Therapy, Combination*
;
Head and Neck Neoplasms*
;
Head*
;
Humans